Significant overexpression of CD164 in SKBR3 cells was found by transcriptomic studies comparing the SKBR3 and MDA-MB-231 breast cancer cell lines, so suggesting its function in the course of breast cancer (41). This evidence concerns the gene CD164 and breast carcinoma.